Lower numbers = closer to natural. Higher numbers = more enhanced.
Why this rating?
Modafinil is a wakefulness-promoting drug used for sleep disorders and off-label as a cognitive/focus enhancer. It does not build muscle, burn fat or alter hormones - its effect is on alertness and, indirectly, training quality via reduced fatigue. The main caveat is that it is a WADA-prohibited in-competition stimulant, so it is not 'natty' for a tested athlete on the doping-eligibility axis even though it does nothing to your physique - it is rated 1 (basically natty) because it does not move the muscular/physique ceiling by any path.
Overview
A wakefulness-promoting medication approved for excessive sleepiness from narcolepsy, obstructive sleep apnea and shift work sleep disorder. Described as a CNS stimulant / atypical dopamine reuptake inhibitor, it is widely used off-label as a cognitive enhancer. Approved in the US in 1998 and sold as Provigil among other brands.
Purpose & Use Cases
Excessive Daytime Sleepiness
FDA-approved to treat excessive sleepiness caused by narcolepsy and obstructive sleep apnea/hypopnea syndrome.
Shift Work Sleep Disorder
Approved for shift work sleep disorder; taken about 1 hour before the start of a work shift.
Off-Label Cognitive Enhancement
Used off-label as a cognitive enhancer by students and professionals seeking improved focus and sustained wakefulness.
Benefits
- Strong, sustained wakefulness without the crash of classic stimulants
- Improved focus and reduced fatigue (basis of off-label cognitive use)
- FDA-approved and well-characterised for sleep disorders
- Long half-life gives all-day coverage from a single morning dose
- Generally well tolerated at standard doses
Good to Know
A wakefulness agent, not a physique drug
Modafinil promotes alertness through atypical dopamine reuptake inhibition. It is FDA-approved (1998) for narcolepsy, obstructive sleep apnea and shift work sleep disorder, and popular off-label for focus. It has no direct anabolic, fat-loss or hormonal action - any training benefit is indirect, from being less tired.
Banned in-competition by WADA since 2004
WADA added modafinil to its Prohibited List on 3 August 2004; it is a prohibited stimulant (category S6) in competitive sport. A tested athlete using it for cognition/wakefulness would still fail an in-competition test.
Watch for rash - the one serious risk
Most side effects are mild (headache, nausea, anxiety, insomnia), but modafinil carries a rare risk of serious skin reactions including Stevens-Johnson syndrome. Any rash means stop and seek care. It is also Schedule IV and can be habit-forming.
Dosage Guidelines
| Experience Level | Dosage Range |
|---|---|
| Beginner | 100 – 100 mg/day |
| Intermediate | 100 – 200 mg/day |
| Advanced | 200 – 400 mg/day |
Available as 100mg and 200mg oral tablets (Wikipedia); taken once a day with or without food (MedlinePlus). 200mg once daily is the standard approved dose; some sources cite up to 400mg but without clearly greater benefit. Take in the morning to avoid insomnia. May be habit-forming - do not exceed the prescribed dose or duration.
Side Effects
Headache
commonThe most common side effect.
Hydration; lower dose if persistent.
Nausea
commonMild gastrointestinal upset.
Take with food if needed.
Anxiety / Insomnia
commonStimulant-related anxiety and trouble sleeping, especially with late dosing.
Dose in the morning; reduce dose.
Decreased Appetite
commonReduced appetite is among the most frequently reported side effects in clinical trials.
Ensure adequate meal timing/intake even when appetite is blunted.
Serious Skin Reactions
rareRare but serious severe skin rashes, including Stevens-Johnson syndrome.
Stop immediately and seek urgent medical care at the first sign of rash.
General Mitigation Strategies
Take once in the morning to limit insomnia. Stop the drug and seek medical attention immediately if any rash develops (rare risk of Stevens-Johnson syndrome). It may be habit-forming, so use only at prescribed doses and durations.
Post Cycle Therapy (PCT)
Not a hormone and does not affect the HPTA. No PCT required.
How It Works
Modafinil is characterised as a central nervous system stimulant and an atypical dopamine reuptake inhibitor - it raises extracellular dopamine (and engages other wake-promoting pathways) to promote alertness. It is functionally a wakefulness agent rather than a classic amphetamine-type stimulant.
Fundamentals
Reference on the practices relevant to Modafinil: how they are done and where they go wrong. Not a recommendation to use it.
Legal Status
Schedule IV controlled substance (USA); prescription-only.
Legal status varies by country and changes over time. This is a general summary, not legal advice.
WADA Status
Modafinil is banned in competitive sport by WADA, which added it to the Prohibited List on 3 August 2004 (per Wikipedia). It is a prohibited stimulant (S6), prohibited in-competition.